Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Tattevin

Showing results (21-30 of 360) with videos related to

Pageof 36
Sort By:
The New England Journal of Medicine|January 29, 2005
Caspofungin versus liposomal amphotericin B for empirical therapyPierre Tattevin, Benoît Bareau, Christophe Camus
La Revue Du Praticien|December 5, 2018
[Treatment of tuberculosis: what's new?]Matthieu Revest, Marion Baldeyrou, Pierre Tattevin
The American Journal of Medicine|January 3, 2015
The replyPierre Fillatre, Matthieu Revest, Pierre Tattevin
The New England Journal of Medicine|April 23, 2020
Prevention of Early Ventilator-Associated PneumoniaNicolas Massart, Pierre Fillatre, Pierre Tattevin
Heart (British Cardiac Society)|May 10, 2017
Machine learning to support decision-making for cardiac surgery during the acute phase of infective endocarditisErwan Donal, Erwan Flecher, Pierre Tattevin
The New England Journal of Medicine|November 12, 2010
Maternal or infant antiretroviral drugs to reduce HIV-1 transmissionPierre Tattevin, Cédric Arvieux, Christian Courpotin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2009
Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection biasPierre Tattevin, Fabrice Uhel, Fabien Fily
Archives of Internal Medicine|January 27, 2010
Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis?Pierre Tattevin, Erwan Donal, Matthieu Revest
Research in Microbiology|April 16, 2009
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated responsePierre Tattevin, Li Basuino, Henry F Chambers
La Revue Du Praticien|January 16, 2014
[Antibiotic prescription and surveillance]Solène Patrat-Delon, Matthieu Revest, Pierre Tattevin
Pageof 36

Showing results (21-30 of 360) with videos related to

Sort By:
Pageof 36
The New England Journal of Medicine|January 29, 2005
Caspofungin versus liposomal amphotericin B for empirical therapyPierre Tattevin, Benoît Bareau, Christophe Camus
La Revue Du Praticien|December 5, 2018
[Treatment of tuberculosis: what's new?]Matthieu Revest, Marion Baldeyrou, Pierre Tattevin
The American Journal of Medicine|January 3, 2015
The replyPierre Fillatre, Matthieu Revest, Pierre Tattevin
The New England Journal of Medicine|April 23, 2020
Prevention of Early Ventilator-Associated PneumoniaNicolas Massart, Pierre Fillatre, Pierre Tattevin
Heart (British Cardiac Society)|May 10, 2017
Machine learning to support decision-making for cardiac surgery during the acute phase of infective endocarditisErwan Donal, Erwan Flecher, Pierre Tattevin
The New England Journal of Medicine|November 12, 2010
Maternal or infant antiretroviral drugs to reduce HIV-1 transmissionPierre Tattevin, Cédric Arvieux, Christian Courpotin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2009
Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection biasPierre Tattevin, Fabrice Uhel, Fabien Fily
Archives of Internal Medicine|January 27, 2010
Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis?Pierre Tattevin, Erwan Donal, Matthieu Revest
Research in Microbiology|April 16, 2009
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated responsePierre Tattevin, Li Basuino, Henry F Chambers
La Revue Du Praticien|January 16, 2014
[Antibiotic prescription and surveillance]Solène Patrat-Delon, Matthieu Revest, Pierre Tattevin
Pageof 36